Molecular Oncology
Volume 3, Issue 1 , Pages 24-32 , February 2009

Biomarkers in oncology drug development

  • Darren R. Hodgson

      Affiliations

    • Oncology Therapy Area, AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 (0) 1625 516105; fax: +44 (0) 1625 516563.
    • ,
  • Robin D. Whittaker

      Affiliations

    • Oncology Therapy Area, AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, UK
    • ,
  • Athula Herath

      Affiliations

    • Statistical Science, AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, UK
    • ,
  • Dereck Amakye

      Affiliations

    • Oncology Therapy Area, AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, UK
    • ,
  • Glen Clack

      Affiliations

    • Oncology Therapy Area, AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, UK

Received 29 November 2008 ,Accepted 2 December 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1574-7891(08)00152-X

doi: 10.1016/j.molonc.2008.12.002

Molecular Oncology
Volume 3, Issue 1 , Pages 24-32 , February 2009

Article Tools

* Image Usage & Resolution